Alcon Announces Launch of Systane Complete Preservative-Free Lubricant Eye Drops in Europe
12 Janvier 2022 - 07:00AM
Business Wire
- Clinically proven to relieve all types of dry eye,1 Systane
Complete is now preservative-free and available in a multi-dose
bottle
- Joins the fast-growing, preservative-free segment of
artificial tears, representing over 40% of the global
category2
- Additional market launches, including the U.S. and
Australia, planned to follow in early 2022
Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated
to helping people see brilliantly, announced today the European
launch of the newest addition to its innovative portfolio of dry
eye products – Systane® Complete Preservative-Free Lubricant Eye
Drops, now in an easy-to-use, multi-dose bottle.
Systane is the leading global artificial tear brand.2 With the
launch of Systane Complete Preservative-Free, Alcon now offers a
full portfolio of preservative-free artificial tears in multi-dose
bottles. This expands Alcon’s footprint in the large and
fast-growing artificial tears category, which is approximately $1
billion in annual sales. Preservative-free is the fastest-growing
segment, representing over 40% of the artificial tears
category.2
“Almost half of all dry eye patients are self-diagnosed and
often do not know which eye drop to choose,”3 said Andy Pawson,
President & General Manager, Global Vision Care Franchise at
Alcon. “Our latest innovation, Systane Complete Preservative-Free,
provides relief for all major types of dry eye for up to eight
hours.1 Frequent users of artificial tears, or those with sensitive
eyes, should be able to effectively and conveniently manage their
symptoms to get back to enjoying their daily lives.”
The Systane Complete Preservative-Free formula works to provide
all-in-one dry eye relief with one drop1 by hydrating and
protecting all layers of the tear film.3,4 Alcon’s proprietary
formula uses intelligent moisture and lipid delivery to enhance
dispersion across the surface of the eye to stabilize the tear
film.4 Its advanced, nano-droplet technology allows for fast-acting
hydration, tear evaporation protection, and long-lasting relief for
a patient’s eyes.4
To ensure the safe delivery of the preservative-free artificial
tear, the bottle’s closing tip system was designed using patented
PureFlow® technology. The bottle has a one-way valve to ensure that
no contaminated liquid is re-introduced into the container after a
drop has been dispensed, eliminating the need for preservatives in
the eye drops.
Systane Complete Preservative-Free joins fast-acting Systane
Ultra Preservative-Free and long-lasting Systane Hydration
Preservative-Free for a full portfolio of multi-dose,
preservative-free dry eye relief products for mild to chronic dry
eye patients.
“So many patients in our community are self-diagnosing their dry
eye symptoms, whether due to increased screen time or other
activities,” said Dr. Ben LaHood, ophthalmologist at the Ashford
Advanced Eye Care clinic in South Australia. Cheryl Donnelly,
International Head of Professional Affairs at Alcon, added, “I’m
glad to see Alcon’s multi-dose, preservative-free portfolio evolve
to include Systane Complete, an all-in-one solution for these
patients’ dry eye symptoms.”
The launch starts in markets throughout Europe and will extend
to the U.S., Australia and additional markets throughout 2022.
Important Information for the Systane
Family of Products
Systane lubricant eye drops have been clinically proven to
reduce the symptoms of dry eye, providing fast, long-lasting relief
and comfort. Systane is the #1 global consumer brand of artificial
tears.2 Systane Complete provides symptom relief for people who
suffer from evaporative dry eye, aqueous tear-deficient dry eye or
mixed dry eye. While Systane Ultra is designed for dry eye with
aqueous deficient patients, Systane Balance lubricant eye drops are
designed specifically for patients with evaporative dry eye
associated with meibomian gland dysfunction. Systane Hydration
gives long-lasting relief of dry eye symptoms for moderate or
chronic sufferers or patients who are recovering from corneal or
other eye surgery.6
About Alcon
Alcon helps people see brilliantly. As the global leader in eye
care with a heritage spanning more than seven decades, we offer the
broadest portfolio of products to enhance sight and improve
people’s lives. Our Surgical and Vision Care products touch the
lives of more than 260 million people in over 140 countries each
year living with conditions like cataracts, glaucoma, retinal
diseases and refractive errors. Our more than 23,000 associates are
enhancing the quality of life through innovative products,
partnerships with Eye Care Professionals and programs that advance
access to quality eye care. Learn more at www.alcon.com.
References
- Silverstein S. Yeu E, Tauber J. et al. Symptom Relief Following
a Single Dose of Propylene Glycol-Hydroxypropyl Guar Nanoemulsion
in Patients with Dry Eye Disease: A Phase IV. Multicenter
Trial.Clin Ophthalmol.2020;14:3167-3177.m.
- Based on internal calculations by Alcon using third-party data;
Alcon data on file, 2021.
- Consumer Eye Drop Research, Global Path-To-Purchase; Alcon data
on file, 2017.
- Ketelson H, Rangarjan R. Pre-clinical evalusation of a nael
phospholipid nanoemulsion based lubricant eye drops.Poster
presented at ARVO 2017, Baltimore, MD.
- Rangarajan R, Ketelson H. Preclinical evaluation of a new
hydroxypropyl-guar phospholipid nanoemulsion-based artificial tear
formulation in models ofcorneal epithelium. J Ocul Pharmacol Ther.
2019;35(1):32-37.
- Rangarajan R, Kraybill B, Ogundele A, Ketelson H. Effects of a
Hyaluronic Acid/Hydroxypropyl Guar Artificial Tear Solution on
Protection, Recovery, and Lubricity in Models of Corneal
Epithelium. J Ocul Pharmacol Ther. 2015;31(8):491-497.
Connect with us on Facebook LinkedIn
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220111006101/en/
Investor Relations Allen
Trang + 41 589 112 110 (Geneva) + 1 817 615 2789 (Fort Worth)
investor.relations@alcon.com
Media Relations Steven Smith
+ 41 589 112 111 (Geneva) + 1 817 551 8057 (Fort Worth)
globalmedia.relations@alcon.com
Alcon (NYSE:ALC)
Graphique Historique de l'Action
De Fév 2024 à Mar 2024
Alcon (NYSE:ALC)
Graphique Historique de l'Action
De Mar 2023 à Mar 2024